相关实验视频

Updated: May 28, 2025

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

安德罗格拉福利德通过向血管生成和诱导CAM-PDX模型中的亡来抑制宫癌的进展

Wanwan Zou¹, Jun Lou², Yun Yi²

¹Jiangxi Provincial Cancer Hospital.

Biomolecules & biomedicine

|February 12, 2025

概括

安德罗格拉福利德 (AND) 通过减少血管形成和促进癌细胞死亡,有效地抑制宫癌的生长. 这项研究验证了用于高级宫癌治疗的新药查模型.

科学领域:

在瘤学瘤学.
药理学药理学是指药理学的学科.
生物技术是生物技术.

背景情况:

宫癌带来了重大挑战,特别是在晚期.
安德罗格拉菲斯 (Andrographis paniculata) 的产物是andrographolide (AND),一种具有治疗潜力的生物活性化合物.
现有的治疗模式需要验证才能进行有效的药物查.

研究的目的:

评估andrographolide (AND) 对宫癌的治疗疗效.
为药物评估建立和验证一个胚胎胆 ?? 膜患者衍生的异种移植 (CAM-PDX) 模型.
研究AND在子宫癌中的抗血管性和抗增殖机制.

主要方法:

开发和验证CAM-PDX模型使用血素-素 (H&E) 染色和免疫组织化学.
在已建立的CAM-PDX模型中,使用20mg/kg的AND剂量.
通过免疫组织化学评估瘤生长,血管生成和蛋白质表达 (Ki67,BCL-2,ERG).

主要成果:

该CAM-PDX模型准确地复制了来自患者的异种移植特征,证实了其可靠性.
并且在CAM-PDX模型中显著抑制了宫癌瘤的生长.
并且减少了瘤血管生成和下调关键蛋白 (Ki67,BCL-2,ERG),表明细胞循环停止和亡诱导.

结论:

一个可重复的CAM-PDX模型已成功建立用于宫癌药物评估.
安德罗格拉福利德 (AND) 通过向血管生成和促进细胞亡,表现出显著的抗瘤活性.
并且作为宫癌的治疗候选人显示出希望,值得进一步的临床研究.

更多相关视频

Author Spotlight: Developing Multiplexed Kinetic Assays for Organoid-Based Drug Response Analysis

Author Spotlight: Developing Multiplexed Kinetic Assays for Organoid-Based Drug Response Analysis

Published on: January 5, 2024

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

相关概念视频

Inhibition of Cdk Activity

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...